Sarina Tanimoto
Co-founder and Chief Medical Officer @ARS Pharmaceuticals, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Co-founder and Chief Medical Officer @ARS Pharmaceuticals, Inc.
San Diego, CA, US
Oversees pipeline of clinical development programs, direct medical/physician oversight research and drug development of ARS-1, an epinephrine nasal spray that could transform the treatment of severe allergic reactions that may lead to anaphylaxis for patients and their families.Founder, Managing Director and Chief Medical Officer
EDUCATION
McGill University
MBA, International Business
University of Toyama
MD
National Institute of Public Health
MPH
日本医科大学 / Nippon Medical School
PhD, Health Care Administration
ABOUT SARINA TANIMOTO
Dr. Sarina Tanimoto offers more than 20 years of pharmaceutical experience in clinical drug development, including participating in the approval of several medicines.Dr. Tanimoto is a co-founder and chief medical officer at ARS Pharmaceuticals, Inc, a company dedicated to providing at-risk patients and their families better protection from severe allergic reactions. Dr. Tanimoto is also chief medical officer at Pacific-Link Regulatory Consulting. In this role, she has supported multiple programs over the last eight years, from Phase 1 to Phase 3 clinical trials in various therapeutic areas, including several intranasal products. Before that, Dr. Tanimoto held roles in clinical and business development during her tenure at AnGes Inc. She has also served as a clinical scientist at Roche, where she was involved in global clinical development.Dr. Tanimoto earned an M.D. from University of Toyama, followed by internal medicine training at the National Center for Global Health and Medicine in Tokyo. She holds an M.B.A. from McGill University.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.